New Therapeutic Options Could Shift Prostate Cancer Treatment

On Demand

Duration: 60 Minutes

Original Date: October 31, 2024

First name

Last name

Business email

Business phone

Company

Job role

Industry

City

Country or Region

State or Province Optional

Yes, I would like to be contacted by a representative to learn more about Bloomberg's solutions and services.

What are you interested in learning more about?

By submitting this information, I agree to the privacy policy and to learn more about products and services from Bloomberg.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

We will discuss the current prostate cancer treatments and key catalysts for older drugs facing loss of exclusivity. We will also discuss new therapies for prostate cancer, with protein degraders and T-cell engagers both aiming to hit the market in the near future.

Speakers

Max Nisen

Analyst

Bloomberg Intelligence

New Therapeutic Options Could Shift Prostate Cancer Treatment

Speakers

Access a broad range of analysis, research, insight and actionable ideas with Bloomberg webinars.